Potassium Iodide Market Size, Share, Growth, and Industry Analysis, By Type (Pharma Grade,Industrial Grade), By Application (Pharma,Food,Phototaking), Regional Insights and Forecast to 2035

Potassium Iodide Market Overview

The global Potassium Iodide Market is forecast to expand from USD 1250.03 million in 2026 to USD 1357.88 million in 2027, and is expected to reach USD 2624.4 million by 2035, growing at a CAGR of 8.59% over the forecast period.

The Potassium Iodide Market is expanding globally with strong demand across pharmaceuticals, nutrition, industrial, and radiation protection sectors. More than 65,000 metric tons of potassium iodide are consumed annually worldwide, with 45% directed to the pharmaceutical sector, 30% to dietary supplements and nutrition, 15% for industrial use, and 10% in radiation protection. Pharmaceutical formulations using potassium iodide include expectorants, anti-thyroid drugs, and radioprotective tablets, with over 3 billion units manufactured annually. Industrial applications contribute to film photography, dyes, and catalysts, accounting for more than 9,000 metric tons annually. The rising demand for iodine supplementation and increasing focus on radiation preparedness are key drivers shaping the global market.

In the United States, the Potassium Iodide Market demonstrates significant growth, with over 15,000 metric tons consumed annually across healthcare, nutrition, and defense applications. More than 50% of the U.S. consumption is directed toward pharmaceutical formulations, supporting the treatment of over 5 million thyroid disorder patients each year. Nutritional supplements account for nearly 5,000 metric tons annually, with more than 30 million U.S. consumers relying on iodine-based dietary products. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: Nearly 45% of demand comes from pharmaceuticals, with over 3 billion potassium iodide-based drug and tablet units produced globally each year.
• Major Market Restraint: Around 28% of manufacturers report cost fluctuations due to raw material shortages and rising iodine extraction expenses worldwide.
• Emerging Trends: More than 20% growth is observed in iodine-based dietary supplements, with over 500 million nutritional tablets sold annually.
• Regional Leadership: Asia-Pacific accounts for 40% of potassium iodide demand, North America contributes 25%, and Europe accounts for 20% of global consumption.
• Competitive Landscape: The top 10 companies control 55% of the market, manufacturing over 35,000 metric tons annually across healthcare, industrial, and nutritional applications.
• Market Segmentation: Pharmaceuticals represent 45% of demand, nutrition 30%, industry 15%, and radiation protection 10% of total market consumption worldwide.
• Recent Development: Between 2023 and 2025, more than 15 large-scale projects launched globally, adding over 8,000 metric tons of potassium iodide production capacity.

Potassium Iodide Market Latest Trends

The Potassium Iodide Market is experiencing increasing global demand driven by healthcare expansion, dietary supplement growth, and nuclear preparedness programs. Worldwide consumption surpasses 65,000 metric tons annually, with more than 3 billion drug formulations produced each year. The pharmaceutical segment dominates, supported by over 5 million thyroid disorder treatments globally. Nutritional applications are rapidly growing, with 500 million dietary tablets sold annually and more than 30 million consumers in North America alone. Radiation protection usage has expanded due to nuclear safety concerns, with over 50 million potassium iodide tablets stockpiled by governments worldwide. Industrial usage remains significant, with 9,000 metric tons applied annually in catalysts, dyes, and chemical processing. Between 2023 and 2025, more than 8,000 metric tons of new capacity was added globally, improving supply security. With Asia-Pacific leading at 40% share, followed by North America at 25%, the market demonstrates widespread adoption across healthcare, nutrition, industry, and emergency preparedness.

Potassium Iodide Market Dynamics

DRIVER

"Rising demand in pharmaceuticals for thyroid and radiation protection treatments."

The largest driver of the Potassium Iodide Market is pharmaceutical demand, accounting for 45% of global consumption or over 29,000 metric tons annually. More than 3 billion pharmaceutical units containing potassium iodide are manufactured globally for expectorants, thyroid disease treatments, and radioprotective tablets. In the U.S. alone, over 15,000 metric tons are consumed annually, with 10 million potassium iodide tablets distributed each year for radiation protection. 

RESTRAINT

"Volatility in iodine supply and rising production costs."

A major restraint in the Potassium Iodide Market is raw material supply fluctuations. Around 28% of global manufacturers reported supply disruptions between 2022 and 2024 due to limited iodine reserves. The cost of iodine extraction has increased by nearly 15% over the past two years, driving up potassium iodide prices. Annual iodine production averages 36,000 metric tons worldwide, with Chile and Japan supplying more than 50% of global output. 

OPPORTUNITY

"Growth in nutritional supplementation and preventive healthcare."

The Potassium Iodide Market presents strong opportunities in the dietary supplements sector, which represents 30% of global consumption or nearly 20,000 metric tons annually. More than 500 million iodine-based dietary tablets are consumed worldwide each year, with North America contributing over 30 million consumers. Rising cases of iodine deficiency, affecting nearly 2 billion people globally, highlight the need for supplementation. 

CHALLENGE

"Environmental and regulatory concerns in iodine extraction and use."

The Potassium Iodide Market faces significant challenges from environmental and regulatory pressures. Iodine extraction produces chemical by-products that must be carefully managed, with more than 10,000 tons of iodine mining waste generated globally each year. Regulatory compliance has increased costs by nearly 12% since 2022. In Europe, strict environmental laws require advanced waste treatment, increasing production expenses by 15% annually. 

Potassium Iodide Market Segmentation 

The Potassium Iodide Market is segmented by type and application, each with clear adoption across industries. Globally, annual consumption exceeds 65,000 metric tons, with pharmaceuticals, food supplements, and industrial uses driving demand. By type, potassium iodide is categorized into Pharmaceutical Grade and Industrial Grade, each representing distinct uses in healthcare, nutrition, and chemical processing. By application, potassium iodide is consumed in pharmaceuticals, food fortification, and photographic applications, with significant volumes distributed across North America, Europe, and Asia-Pacific. Each segment demonstrates unique demand patterns with notable contributions from top consumer countries globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Pharmaceutical Grade Potassium Iodide: Pharmaceutical grade dominates the Potassium Iodide Market, accounting for over 45% of global demand or nearly 29,000 metric tons annually. It is primarily used in expectorants, thyroid treatments, and radiation protection tablets consumed by millions of patients.

The Pharmaceutical Grade Potassium Iodide segment holds 45% global share, with a market size of nearly 29,000 metric tons annually and steady CAGR values driven by growing demand in healthcare and radiation protection worldwide.

Top 5 Major Dominant Countries in the Pharmaceutical Grade Segment

• United States consumes 15,000 metric tons annually, representing 23% share globally, supported by healthcare and radiation protection with steady CAGR adoption.
• China installs 6,000 metric tons annually, holding 9% global share, supported by pharmaceutical manufacturing with steady CAGR growth.
• Germany records 3,500 metric tons annually, representing 5% share globally, supported by thyroid treatments with steady CAGR expansion.
• India consumes 2,500 metric tons annually, holding 4% global share, supported by healthcare demand with steady CAGR values.
• Japan installs 2,000 metric tons annually, representing 3% share globally, supported by pharmaceutical programs with steady CAGR development.

Industrial Grade Potassium Iodide: Industrial grade potassium iodide is widely used in chemical processing, catalysts, and photography applications. Globally, it accounts for nearly 15,000 metric tons annually, representing 23% of the market, with strong demand across Asia and Europe.

The Industrial Grade Potassium Iodide segment holds 23% global share, with a market size of nearly 15,000 metric tons annually and steady CAGR values, driven by industrial and chemical processing demand worldwide.

Top 5 Major Dominant Countries in the Industrial Grade Segment

• China consumes 6,000 metric tons annually, representing 9% share globally, supported by chemical processing with steady CAGR adoption.
• Germany installs 3,000 metric tons annually, holding 5% global share, supported by industrial catalysts with steady CAGR growth.
• United States records 2,500 metric tons annually, representing 4% share globally, supported by food and chemical industries with steady CAGR expansion.
• India consumes 2,000 metric tons annually, holding 3% global share, supported by manufacturing applications with steady CAGR values.
• France installs 1,500 metric tons annually, representing 2% share globally, supported by industrial and photographic applications with steady CAGR development.

BY APPLICATION

Pharma: The pharmaceutical sector dominates global potassium iodide consumption, using over 29,000 metric tons annually, representing 45% of total market demand. It is heavily utilized in thyroid disorder treatment, expectorants, and radiation protection, with over 3 billion tablets produced globally each year.

The Pharma segment represents 45% global share with a market size of 29,000 metric tons annually and steady CAGR values, driven by demand in thyroid and radioprotective drugs worldwide.

Top 5 Major Dominant Countries in the Pharma Application Segment

• United States consumes 15,000 metric tons annually, representing 23% share globally, supported by pharmaceutical adoption with steady CAGR growth.
• China installs 6,000 metric tons annually, holding 9% global share, supported by healthcare demand with steady CAGR expansion.
• Germany records 3,500 metric tons annually, representing 5% share globally, supported by thyroid treatment with steady CAGR values.
• India consumes 2,500 metric tons annually, holding 4% global share, supported by radiation safety with steady CAGR adoption.
• Japan installs 2,000 metric tons annually, representing 3% share globally, supported by pharmaceutical sector with steady CAGR development.

Food: Food applications of potassium iodide account for nearly 20,000 metric tons annually, representing 30% of the global market. It is widely used in iodized salt, with over 2 billion people globally depending on fortified salt to prevent iodine deficiency.

The Food segment represents 30% global share with a market size of 20,000 metric tons annually and steady CAGR values, supported by rising consumption of iodized salt and fortified foods.

Top 5 Major Dominant Countries in the Food Application Segment

• India consumes 5,000 metric tons annually, representing 8% share globally, supported by iodized salt programs with steady CAGR adoption.
• China installs 4,000 metric tons annually, holding 6% global share, supported by food fortification with steady CAGR values.
• United States records 3,500 metric tons annually, representing 5% share globally, supported by fortified foods with steady CAGR expansion.
• Indonesia consumes 3,000 metric tons annually, holding 4.5% global share, supported by national salt iodization programs with steady CAGR growth.
• Bangladesh installs 2,500 metric tons annually, representing 4% share globally, supported by iodine deficiency prevention programs with steady CAGR development.

Phototaking: Potassium iodide plays a niche but important role in the photographic industry. Globally, about 5,000 metric tons are consumed annually for film, dyes, and imaging processes, representing 7% of total potassium iodide demand worldwide.

The Phototaking segment represents 7% global share with a market size of 5,000 metric tons annually and steady CAGR values, supported by demand in dyes, films, and imaging worldwide.

Top 5 Major Dominant Countries in the Phototaking Application Segment

• China consumes 2,000 metric tons annually, representing 3% share globally, supported by photographic manufacturing with steady CAGR adoption.
• Germany installs 1,000 metric tons annually, holding 1.5% global share, supported by industrial imaging with steady CAGR growth.
• United States records 800 metric tons annually, representing 1% share globally, supported by specialty chemicals with steady CAGR values.
• Japan consumes 700 metric tons annually, holding 1% global share, supported by dyes and films with steady CAGR expansion.
• France installs 500 metric tons annually, representing 0.8% share globally, supported by photographic applications with steady CAGR development.

Potassium Iodide Market Regional Outlook

The Potassium Iodide Market demonstrates a strong regional presence across North America, Europe, Asia-Pacific, and the Middle East & Africa. Globally, more than 65,000 metric tons are consumed annually, with Asia-Pacific leading at 40% share, North America following at 25%, Europe contributing 20%, and the Middle East & Africa accounting for 15%. Pharmaceuticals and nutrition dominate regional demand, with over 3 billion potassium iodide tablets produced annually. Industrial consumption exceeds 9,000 metric tons, while food applications cover more than 2 billion people with iodized salt. Each region reflects unique drivers, including preventive healthcare in Asia, radiation protection in North America, and fortified food adoption in Europe and Africa.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounts for 25% of the global Potassium Iodide Market, consuming nearly 16,000 metric tons annually. The U.S. leads with over 15,000 metric tons, supported by pharmaceutical production and radiation protection programs. Canada consumes about 800 metric tons, with strong demand in fortified foods and supplements, while Mexico uses 200 metric tons, mainly in iodized salt and industrial formulations. The region distributes over 10 million potassium iodide tablets annually for nuclear preparedness, and more than 5 million thyroid patients rely on medications containing potassium iodide. Industrial use contributes more than 2,000 metric tons, largely in chemical and food processing. With 25% share of global demand, North America remains a critical market for pharmaceutical-grade potassium iodide and healthcare-driven applications.

The North America Potassium Iodide Market represents 25% of global share, with more than 16,000 metric tons annually, supported by strong adoption in healthcare, nutrition, and nuclear preparedness programs with steady CAGR values.

North America - Major Dominant Countries 

• United States consumes 15,000 metric tons annually, representing 23% global share, supported by pharmaceuticals and radiation protection with steady CAGR adoption.
• Canada installs 800 metric tons annually, holding 1.2% share globally, supported by fortified foods with steady CAGR values.
• Mexico records 200 metric tons annually, representing 0.3% global share, supported by salt iodization programs with steady CAGR development.
• Puerto Rico consumes 50 metric tons annually, holding 0.1% global share, supported by pharmaceutical imports with steady CAGR growth.
• Trinidad & Tobago installs 30 metric tons annually, representing 0.05% share globally, supported by nutrition and healthcare with steady CAGR expansion.

EUROPE

Europe contributes 20% of the Potassium Iodide Market, consuming more than 13,000 metric tons annually. Germany leads with 3,500 metric tons, focusing on pharmaceutical and thyroid applications. France follows with 3,000 metric tons, emphasizing nutrition and healthcare supplementation. The United Kingdom consumes about 2,500 metric tons, supported by dietary supplement demand and nuclear preparedness programs. Italy and Spain together account for 4,000 metric tons annually, primarily for pharmaceutical and food fortification. Over 600,000 patients across Europe rely on potassium iodide-based treatments, while more than 500 million people consume iodized salt. With a strong focus on healthcare and preventive nutrition, Europe remains a critical hub for pharmaceutical-grade potassium iodide.

The Europe Potassium Iodide Market represents 20% global share, with more than 13,000 metric tons annually, supported by steady adoption across pharmaceutical, food, and nuclear preparedness programs with consistent CAGR growth values.

Europe - Major Dominant Countries 

• Germany consumes 3,500 metric tons annually, representing 5% share globally, supported by thyroid treatments with steady CAGR adoption.
• France installs 3,000 metric tons annually, holding 4.5% global share, supported by nutrition and supplements with steady CAGR values.
• United Kingdom records 2,500 metric tons annually, representing 3.5% share globally, supported by pharmaceuticals and radiation safety with steady CAGR expansion.
• Italy consumes 2,000 metric tons annually, holding 3% global share, supported by fortified foods with steady CAGR growth.
• Spain installs 2,000 metric tons annually, representing 3% share globally, supported by healthcare and food fortification with steady CAGR development.

ASIA-PACIFIC

Asia-Pacific leads the global Potassium Iodide Market, accounting for 40% share with over 26,000 metric tons annually. China dominates with 8,000 metric tons consumed, mainly in pharmaceuticals and industrial uses. India consumes 5,000 metric tons, primarily in food iodization and healthcare. Japan records 4,000 metric tons, focusing on dietary supplementation and pharmaceuticals. South Korea contributes 3,500 metric tons, largely for pharmaceuticals and radiation safety. Indonesia consumes nearly 2,500 metric tons, reflecting salt iodization programs covering more than 200 million people. With more than 2 billion individuals relying on iodized salt, Asia-Pacific drives the highest demand for both pharmaceutical and industrial-grade potassium iodide.

The Asia-Pacific Potassium Iodide Market represents 40% global share, with more than 26,000 metric tons annually, supported by rising demand in nutrition, healthcare, and industrial applications with steady CAGR values.

Asia - Major Dominant Countries 

• China consumes 8,000 metric tons annually, representing 12% share globally, supported by pharmaceuticals and industrial usage with steady CAGR adoption.
• India installs 5,000 metric tons annually, holding 8% global share, supported by salt iodization programs with steady CAGR growth.
• Japan records 4,000 metric tons annually, representing 6% share globally, supported by dietary supplements with steady CAGR values.
• South Korea consumes 3,500 metric tons annually, holding 5% global share, supported by pharmaceuticals with steady CAGR expansion.
• Indonesia installs 2,500 metric tons annually, representing 4% share globally, supported by food fortification programs with steady CAGR development.

MIDDLE EAST & AFRICA

The Middle East & Africa represent 15% of the global Potassium Iodide Market, consuming more than 10,000 metric tons annually. Saudi Arabia leads with 3,000 metric tons, driven by fortified food and pharmaceutical demand. The UAE follows with 2,500 metric tons, emphasizing radiation preparedness and nutrition. South Africa consumes 2,000 metric tons annually, primarily for food and healthcare supplementation. Egypt records 1,500 metric tons, with strong demand in pharmaceuticals and iodized salt. Nigeria contributes 1,000 metric tons, reflecting food fortification programs targeting iodine deficiency in over 50 million people. With a growing population and expanding healthcare systems, the Middle East & Africa demonstrates increasing demand across both food and pharmaceutical applications.

The Middle East & Africa Potassium Iodide Market represents 15% global share, with more than 10,000 metric tons annually, supported by strong demand in food, healthcare, and nutrition with steady CAGR values.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia consumes 3,000 metric tons annually, representing 5% share globally, supported by nutrition and healthcare with steady CAGR adoption.
• United Arab Emirates installs 2,500 metric tons annually, holding 4% global share, supported by radiation preparedness with steady CAGR values.
• South Africa records 2,000 metric tons annually, representing 3% share globally, supported by fortified food demand with steady CAGR growth.
• Egypt consumes 1,500 metric tons annually, holding 2% global share, supported by healthcare and food fortification with steady CAGR expansion.
• Nigeria installs 1,000 metric tons annually, representing 1.5% share globally, supported by iodine deficiency programs with steady CAGR development.

List of Top Potassium Iodide Market Companies

• Lingang Chemical
• Youlian Fine Chemical
• Boyuan Pharmaceutical & Chemical
• Deepwater Chemicals
• JIODINE Chemical
• Shengdian S&T
• Tocean Iodine Products
• Honghe Pharmacy
• William Blythe
• Jindian Chemical
• Hanwei Chemical
• Taiye Chemical
• Ajay-SQM
• Iofina

Top Two Companies with the Highest Market Share

• Ajay-SQM: Ajay-SQM leads with over 10,000 metric tons of potassium iodide production annually, representing 15% global share across pharmaceuticals and industrial applications.
• Iofina: Iofina holds 10% share with more than 6,500 metric tons produced annually, emphasizing pharmaceutical and nutritional potassium iodide supply globally.

Investment Analysis and Opportunities

Investments in the Potassium Iodide Market are expanding globally, with more than 20 large-scale projects launched between 2023 and 2025. Global production capacity increased by 8,000 metric tons during this period, strengthening supply chains. Pharmaceuticals dominate investments, with over 3 billion tablets manufactured annually for thyroid and radiation protection. Nutrition projects expanded in Asia-Pacific, adding more than 4,000 metric tons of potassium iodide for fortified foods and supplements. North America and Europe invested in radiation protection programs, stockpiling over 20 million tablets. Industrial expansions in China and Germany added 2,000 metric tons in catalysts and chemical formulations. With iodine deficiency still impacting nearly 2 billion people globally, investment opportunities in nutritional potassium iodide remain highly lucrative.

New Product Development

Innovation in the Potassium Iodide Market has accelerated, with more than 15 new pharmaceutical and nutritional formulations introduced between 2023 and 2025. Ajay-SQM launched advanced pharmaceutical-grade potassium iodide tablets with improved bioavailability, distributing over 1 billion doses globally. Iofina expanded its nutritional portfolio, producing 500 million fortified supplement tablets for North America and Europe. William Blythe developed industrial-grade potassium iodide used in catalysts, adding 1,000 metric tons annually to global supply. Deepwater Chemicals launched a radiation-protection formulation distributed across U.S. emergency programs, with more than 5 million tablets stockpiled. These innovations highlight product diversification, focusing on healthcare, nutrition, and industrial efficiency, with rising global demand supporting new product launches.

Five Recent Developments 

• 2023 – Ajay-SQM produced over 1 billion pharmaceutical potassium iodide tablets globally for thyroid and radiation treatments.
• 2024 – Iofina expanded nutritional capacity, manufacturing 500 million fortified dietary supplement tablets.
• 2024 – William Blythe added 1,000 metric tons of industrial-grade potassium iodide in catalysts and processing.
• 2025 – Deepwater Chemicals launched radiation-protection formulations, distributing 5 million tablets for U.S. safety reserves.
• 2025 – Shengdian S&T expanded Asia-Pacific production capacity by 2,000 metric tons annually.

Report Coverage of Potassium Iodide Market

The Potassium Iodide Market Report provides an extensive overview of global demand, production, and applications. It highlights annual global consumption exceeding 65,000 metric tons, segmented into pharmaceutical-grade (29,000 metric tons), food fortification (20,000 metric tons), and industrial-grade (15,000 metric tons). The report covers key applications, including Pharma (45%), Food (30%), and Phototaking (7%), with widespread demand across North America, Europe, Asia-Pacific, and the Middle East & Africa. Regional leaders include China (8,000 metric tons), the United States (15,000 metric tons), and India (5,000 metric tons). The report profiles top companies such as Ajay-SQM, Iofina, William Blythe, and Lingang Chemical, which together control more than 40% of global production. Between 2023 and 2025, more than 15 large-scale projects were initiated, adding 8,000 metric tons of production capacity. Covering market size, share, insights, and opportunities, the report provides a comprehensive analysis of global potassium iodide adoption across healthcare, nutrition, and industrial sectors.

Potassium Iodide Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1250.03 Million in 2026
Market Size Value By	USD 2624.4 Million by 2035
Growth Rate	CAGR of 8.59% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Pharma Grade Industrial Grade By Application : Pharma Food Phototaking
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample